new/era/mabs
  • services
  • blog

Meet selma: Novel antibody generation four times faster

Katja Hanack

Jun 7, 2021 • 1 min read
Meet selma: Novel antibody generation four times faster

Searching for a fast, flexibel and specific way to generate antibodies ? Learn more about our technology selma in our article Meet selma: Novel antibody generation four times faster published in Research Features.

selma - our groundbreaking technology

selma - our groundbreaking technology

Since decades selection of antibody producing hybridoma cells has been performed by limited dilution and numerous ELISA screenings in order to find suitable antibody-producing cells. These processes are very laborious, time-consuming and expensive. This dilemma motivated us to develop a new selection technology. We developed selma: selma is based on
Katja Hanack Jun 6, 2021 • 1 min read
selma + murine monoclonal antibodies

selma + murine monoclonal antibodies

We base our immunization strategy onto the most efficient danger signals to the mammalian immune system: viruses. By combining efficient surface-related epitopes with a viral particle system originated from the hamster polyomavirus, we are able to perform a hyper-immunization schedule, extraordinarily faster than conventional immunization strategies. In close cooperation with
Katja Hanack Jun 6, 2021 • 2 min read
selma + human monoclonal antibodies

selma + human monoclonal antibodies

With our in house developed in vitro immunisation process we are able to activate naive B lymphocytes antigen-specifically within 12 days and fuse them afterwards with our transgenic fusion cell line. As a result we can identify hybridoma clones producing antigen-specific human IgM or IgG immunoglobulins. For the selection of
Katja Hanack Jun 6, 2021 • 1 min read
new/era/mabs © 2023